4th Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$430,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 18, 2022 $430,000 Replaced
4th Quarter - Amendment Apr 25, 2022 $2,100,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Implementation of pharmacy provisions of Public Law 115-271; H.R. 280, the PDMPs Help Patients Act of 2021; H.R. 2355, the Opioid Prescription Verification Act of 2021; H.R. 768, the Block, Report, And Suspend Suspicious Shipments Act of 2021

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Federal Trade Commission (FTC); Justice, Dept of (DOJ); Health Resources & Services Administration (HRSA); Occupational Safety & Health Administration (OSHA); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Federal Reserve System; Internal Revenue Service (IRS)

Bills named: H.R. 280 (117th), H.R. 2355 (117th), H.R. 768 (117th)

Small Business SMB

H.R. 1799, the PPP Extension Act of 2021; H.R. 1319, the American Rescue Plan Act of 2021; H.R. 2583, the PPP Equity Act of 2021; Interchange Fees/Debit Routing issues; PPP and EIDL funding

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: Federal Trade Commission (FTC); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Justice, Dept of (DOJ); Federal Reserve System; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Centers For Disease Control & Prevention (CDC); Occupational Safety & Health Administration (OSHA); Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); Small Business Administration (SBA); SENATE

Bills named: H.R. 2583 (117th), H.R. 1319 (117th), H.R. 1799 (117th)

Pharmacy PHA

S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution; Pharmacist scope of practice, including authorities established by the Public Readiness and Emergency Preparedness (PREP) Act; H.R. 4390, the PROTECT 340B Act of 2021; S. 1574 / H.R. 5632, the Long-Term Care Pharmacy Definition Act of 2021; Provider Relief Fund; Implementation of Pubic Law 113-54, the Drug Quality and Security Act; H.R. 6005, the Access to Birth Control Act

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); White House Office; Federal Reserve System; SENATE; Centers For Disease Control & Prevention (CDC); Justice, Dept of (DOJ); Occupational Safety & Health Administration (OSHA)

Bills named: H.R. 3655 (117th), H.R. 3662 (117th), H.R. 6005 (117th), H.R. 1829 (117th), S. 298 (117th), S. 1574 (117th), H.R. 5632 (117th), H.R. 4390 (117th), H.R. 3656 (117th)

Medicare/Medicaid MMM

H.R. 3554 / S. 1909, the Pharmacy DIR Reform To Reduce Senior Drug Costs Act; H.R. 2608, the Ensuring Seniors Access to Local Pharmacies Act; H.R. 2759 / S. 1362, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 3682, the Improving Transparency to Lower Drug Costs Act; H.R. 2484, the Lowest Price for Patients Act; H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 / S. 2164, the Lower Costs, More Cures Act of 2021; H.R. 3173, the Improving Seniors Timely Access to Care Act of 2021; H.R. 4121, the PRO Seniors Act; Proposed inclusion of Medicaid managed care spread pricing prohibition to pay for H.R. 3684, the Infrastructure Investment and Jobs Act; H.R. 5237, the Reduced Costs and Continued Cures Act of 2021 H.R. 5376, the Build Back Better Act; H.R. 5804, the Expanding Access to Diabetes Self-Management Training Act of 2021; H.R. 6101, the Drug Price Transparency in Medicaid Act of 2021; Part B billing and COVID oral antivirals

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: Justice, Dept of (DOJ); Occupational Safety & Health Administration (OSHA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); Food & Drug Administration (FDA); SENATE; White House Office; Federal Reserve System; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Drug Enforcement Administration (DEA)

Bills named: S. 1909 (117th), H.R. 5237 (117th), H.R. 6101 (117th), H.R. 2484 (117th), H.R. 3684 (117th), H.R. 5804 (117th), H.R. 2759 (117th), H.R. 3173 (117th), H.R. 3682 (117th), S. 2164 (117th), H.R. 3 (117th), S. 1362 (117th), H.R. 3554 (117th), H.R. 2608 (117th), H.R. 5376 (117th), H.R. 19 (117th), H.R. 4121 (117th)

Taxation/Internal Revenue Code TAX

S. 617 / H.R. 1712, the Death Tax Repeal Act of 2021; H.R. 1381 / S. 480, the Main Street Tax Certainty Act; Draft tax provisions of FY2022 budget reconciliation legislation, including repeal of stepped up basis, S Corps/pass-throughs tax increase proposal, and 199A pass-through Deduction proposal; Treasury Department proposal to require financial institutions reporting deposits and withdrawals of all business and personal accounts to the IRS

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: SENATE; Food & Drug Administration (FDA); Justice, Dept of (DOJ); Small Business Administration (SBA); White House Office; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Federal Reserve System; Drug Enforcement Administration (DEA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Occupational Safety & Health Administration (OSHA)

Bills named: H.R. 1381 (117th), S. 480 (117th), H.R. 1712 (117th), S. 617 (117th)

Labor Issues/Antitrust/Workplace LBR

S. 225, the Competition and Antitrust Law Enforcement Reform Act of 2021; S. 1388, the Prescription Pricing for the People Act of 2021; H.R. 603 / S. 53, the Raise the Wage Act of 2021; H.R. 7, the Paycheck Fairness Act; Promoting Competition in the American Economy Executive Order; UnitedHealth Group proposed merger of Change Healthcare; Unfair Competition and Anticompetitive Contract Terms; Occupational exposure to COVID-19 and vaccine mandates

LobbyistCovered position, as disclosed
ANNE CASSITY —
SHION CHANG —
PHILLIP ADAM HARBISON —
RONNA HAUSER —
KARRY LA VIOLETTE —
PETER JOHN MIHALICK —

Contacted: Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Drug Enforcement Administration (DEA); Occupational Safety & Health Administration (OSHA); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); Treasury, Dept of; Centers For Disease Control & Prevention (CDC); White House Office; Federal Reserve System; SENATE; Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA)

Bills named: S. 1388 (117th), H.R. 603 (117th), S. 53 (117th), H.R. 7 (117th), S. 225 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.